OK, so it turned out to be a much more complicated situation, with many good assays, many having to be returned to the back of the line. 100's...even 1000's of samples, have to be annalyzied into a big picture and fitted into a big puzzle, so it makes sense to them, and as importantly, to shareholders and investors.

I hear your frustration, but this going back and dragging up what was said, after we've all heard it and know it now, is just stirring up the pot, as you say.

OK, so Frank got it wrong....gee, how about that. Well, we know that now, and it's water under the bridge. Sh*# happens. I would say that, if that particular issue is the extent of the complaints against the company, then it pales in comparison to all the many positive attributes I have heard from those that have met and dealt with Frank and the rest of the team.

Let it go, bro'

Pender